Evaluation Ultrasound Elasticity/Tissue Strain-Hardening Imaging for Prostate Cancer Patients Undergoing Radical Prostatectomy

Stopped early · Not applicable

Conditions studied: Prostate Cancer

In brief

The primary objective is to perform a pilot trial evaluation of a novel prostate ultrasound imaging software utilizing tissue elasticity measurements to identify tumor foci among men who will undergo radical prostatectomy for localized prostate cancer. As a secondary objective, investigators will compare elasticity measured tumor foci volume to the measured volume from radical prostatectomy pathologic examination.

Key facts

Study ID

NCT00824902

Run by

M.D. Anderson Cancer Center

People needed

13

Starts

2008-12-01

Expected to finish

2013-11-01

Last updated by the study team

2015-01-09

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients selected for radical prostatectomy (any technique) at MDACC
• Histologic diagnosis of prostate cancer, clinical stage cT1c-cT3b
• Serum prostate specific antigen less than 30 ng/ml.
• Any Gleason score
• Total prostate volume of 20-60 cc, measured by outside ultrasound or clinical examination at MDACC.
• Group 1: high volume disease. At least 3 positive cores containing cancer on one side of the prostate Group 2: low volume disease. Less than 50% tumor length in a single positive core on one side of the prostate

You may not qualify if…

• Prior radiation therapy to the pelvis
• Prior hormonal therapy within 3 months (including LH/RH agonists, estrogens, testosterone receptor blockade, finasteride, dutasteride)

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.